Changes in Beneficial Ownership · 4
Tempus AI, Inc.
TEMNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4-10292026_041001.xml
Filing details
- Report period
- 2026-10-27
- Issuer
- Tempus AI, Inc.
- Issuer CIK
- 0001717115
- Trading symbol
- TEM
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- LEFKOFSKY ERIC P
- Reporting owner CIK
- 0001114357
- Relationship
- Director · Officer · 10% owner
- Officer title
- CEO and Chairman
- Address
- C/O TEMPUS AI, INC., 600 WEST CHICAGO AVENUE, SUITE 510, CHICAGO, IL, 60654
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 10,428 | D | 67.36[F2] | 8,534,855 | I | By Gray Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 7,592 | D | 68[F4] | 8,527,263 | I | By Gray Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 1,495 | D | 69.28[F5] | 8,525,768 | I | By Gray Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 6,312 | D | 70.58[F6] | 8,519,456 | I | By Gray Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 16,414 | D | 71.56[F7] | 8,503,042 | I | By Gray Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 15,259 | D | 72.31[F8] | 8,487,783 | I | By Gray Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 24,597 | D | 67.36[F2] | 14,825,872 | I | By Blue Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 17,825 | D | 68[F4] | 14,808,047 | I | By Blue Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 3,510 | D | 69.28[F5] | 14,804,537 | I | By Blue Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 14,820 | D | 70.58[F6] | 14,789,717 | I | By Blue Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 38,489 | D | 71.56[F7] | 14,751,228 | I | By Blue Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 35,759 | D | 72.31[F8] | 14,715,469 | I | By Blue Media, LLC[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 1,282 | D | 67.36[F2] | 800,849 | I | By Lefkofsky Family Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 961 | D | 68[F4] | 799,888 | I | By Lefkofsky Family Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 195 | D | 69.28[F5] | 799,693 | I | By Lefkofsky Family Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 824 | D | 70.58[F6] | 798,869 | I | By Lefkofsky Family Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 2,167 | D | 71.56[F7] | 796,702 | I | By Lefkofsky Family Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 2,071 | D | 72.31[F8] | 794,631 | I | By Lefkofsky Family Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 9,132 | D | 67.36[F2] | 90,868 | I | By Vas.org Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 6,636 | D | 68[F4] | 84,232 | I | By Vas.org Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 1,300 | D | 69.28[F5] | 82,932 | I | By Vas.org Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 5,486 | D | 70.58[F6] | 77,446 | I | By Vas.org Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 14,237 | D | 71.56[F7] | 63,209 | I | By Vas.org Foundation[F3] |
| Class A Common Stock | 2026-10-27 | S · Form 4[F1] | 13,209 | D | 72.31[F8] | 50,000 | I | By Vas.org Foundation[F3] |
Table key
- S · Form 4
- Sale on the market or privately
- D
- Disposed
- I
- Indirect
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Class A Common Stock | 2,098,130 | D | |
| Class A Common Stock | 406 | I | By 346 Long LLC[F3] |
| Class A Common Stock | 5,715,203 | I | By Lefkofsky Family 2025 GRAT[F3] |
| Class A Common Stock | 206 | I | By Black Media, LLC[F3] |
| Class A Common Stock | 4,284,797 | I | By Lefkofsky Family 2026 GRAT[F3] |
Table key
- D
- Direct
- I
- Indirect
Footnotes
- F1
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 8, 2026.↩ 1↩ 2↩ 3↩ 4↩ 5↩ 6↩ 7↩ 8↩ 9↩ 10↩ 11↩ 12↩ 13↩ 14↩ 15↩ 16↩ 17↩ 18↩ 19↩ 20↩ 21↩ 22↩ 23↩ 24
- F2
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.69 to $67.6836 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1↩ 2↩ 3↩ 4
- F3
- The Reporting Person is (i) a member of, and controls a limited liability company that is a member of, 346 Long LLC, (ii) the sole manager of each of Black Media, LLC, Blue Media, LLC and Gray Media, LLC, (iii) a trustee of each of Lefkofsky Family Foundation and Vas.org Foundation. The Reporting Person's spouse is the trustee of the Lefkofsky Family 2025 GRAT and Lefkofsky Family 2026 GRAT.↩ 1↩ 2↩ 3↩ 4↩ 5↩ 6↩ 7↩ 8↩ 9↩ 10↩ 11↩ 12↩ 13↩ 14↩ 15↩ 16↩ 17↩ 18↩ 19↩ 20↩ 21↩ 22↩ 23↩ 24↩ 25↩ 26↩ 27↩ 28
- F4
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.69 to $68.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1↩ 2↩ 3↩ 4
- F5
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.75 to $69.74 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1↩ 2↩ 3↩ 4
- F6
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.05 to $71.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1↩ 2↩ 3↩ 4
- F7
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.045 to $72.0442 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1↩ 2↩ 3↩ 4
- F8
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.045 to $72.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1↩ 2↩ 3↩ 4
Signature 1
- Signed
- /s/ Andrew Polovin, Attorney-in-Fact
- Date
- 2026-10-29
Company context
Tempus is a technology company making precision medicine a reality through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of de-identified multimodal data and an intelligent operating system that makes that data accessible and actionable, Tempus connects AI, diagnostics and clinical workflows to deliver more personalized patient care and accelerate the discovery, development and delivery of better medicines. By continuously transforming data into insights, Tempus